Complications of oncologic therapy in the abdomen and pelvis: A review

Abdominal Imaging

Volumn 38, Issue 1, 2013, Pages 1-21

  Ganeshan, Dhakshina Moorthy ^a   Salem, Usama ^a,b   Viswanathan, Chitra ^a   Balachandran, Aparna ^a   Garg, Naveen ^a   Silverman, Paul ^a   Bhosale, Priya ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Abdominal imaging; Cancer therapy complications; Chemotherapy complications; Pelvic imaging; Radiotherapy complications

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BARIUM; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; ERLOTINIB; FLOXURIDINE; FLUDARABINE; FLUOROURACIL; FOLINIC ACID; GEFITINIB; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN; NAVELBINE; NITROSOUREA; OXALIPLATIN; PACLITAXEL; RETINOIC ACID; SORAFENIB; SUNITINIB; UNINDEXED DRUG;

ABDOMINAL CANCER; ABDOMINAL RADIOGRAPHY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DUODENUM ULCER; ENDOMETRIAL DISEASE; ENTERITIS; FATTY LIVER; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE PERFORATION; ISCHEMIC COLITIS; LIVER CIRRHOSIS; LIVER VEIN OBSTRUCTION; LYMPHOPROLIFERATIVE DISEASE; MOLECULARLY TARGETED THERAPY; NEPHROTOXICITY; NEUROGENIC BLADDER; NEUTROPENIC ENTEROCOLITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PELVIS CANCER; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RADIATION CARCINOGENESIS; RADIATION INJURY; REVIEW; SPLEEN RUPTURE; SPLENOMEGALY; STOMACH ULCER; TUMOR LYSIS SYNDROME; VASCULAR DISEASE;

ABDOMEN; ANTINEOPLASTIC AGENTS; BLOOD VESSELS; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM; HUMANS; NEOPLASMS; PELVIS; RADIOTHERAPY; UROGENITAL SYSTEM;

EID: 84872675434     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9899-x     Document Type: Review

References (144)

1. Kwek JW, Iyer RB, Dunnington J, Faria S, Silverman PM (2006) Spectrum of imaging findings in the abdomen after radiotherapy. AJR Am J Roentgenol 187(5):1204-1211. doi: 10.2214/ajr.05.0941 (Pubitemid 44630823)
2. Yeoh EK, Horowitz M (1987) Radiation enteritis. Surg Gynecol Obstet 165(4):373-379 (Pubitemid 17161537)
3. Lawrence TS, Robertson JM, Anscher MS, et al. (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31(5):1237-1248
4. Hall DA, Clouse ME, Gramm HF (1981) Gastroduodenal ulceration after hepatic arterial infusion chemotherapy. AJR Am J Roentgenol 136(6):1216-1218 (Pubitemid 12236572)
5. Hohn DC, Stagg RJ, Price DC, Lewis BJ (1985) Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2′-deoxyuridine. J Clin Oncol 3(9):1257-1260 (Pubitemid 15226532)
6. Kelvin FM, Gramm HF, Gluck WL, Lokich JJ (1986) Radiologic manifestations of small-bowel toxicity due to floxuridine therapy. AJR Am J Roentgenol 146(1):39-43 (Pubitemid 16174344)
7. Torrisi JM, Schwartz LH, Gollub MJ, et al. (2011) CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 258(1):41-56. doi: 10.1148/radiol.10092129
8. Davila M, Bresalier RS (2008) Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol 5(12):682-696. doi: 10.1038/ncpgasthep1277
9. Benson AB 3rd, Ajani JA, Catalano RB, et al. (2004) Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22(14):2918-2926 (Pubitemid 41079912)
10. Ikuno N, Soda H, Watanabe M, Oka M (1995) Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J Natl Cancer Inst 87(24):1876-1883
11. Tavakkolizadeh A, Shen R, Abraham P, et al. (2000) Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis. J Surg Res 91(1):77-82 (Pubitemid 30340900)
12. Douillard JY, Cunningham D, Roth AD, et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355(9209):1041-1047 (Pubitemid 30162806)
13. Kuebler JP, Colangelo L, O'Connell MJ, et al. (2007) Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis. Cancer 110(9):1945-1950 (Pubitemid 350036852)
14. Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S (2001) Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol 19(18):3801-3807 (Pubitemid 32880058)
15. Saltz LB, Cox JV, Blanke C, et al. (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343(13):905-914
16. Zamani R, Heldmann M (2004) Enteritis as a complication of adjuvant combination chemotherapy using 5-fluorouracil and leukovorin: clinical and helical computed tomographic features. J La State Med Soc 156(3):143-144
17. Asnacios A, Naveau S, Perlemuter G (2009) Gastrointestinal toxicities of novel agents in cancer therapy. Eur J Cancer 45(Suppl 1):332-342. doi: 10.1016/s0959-8049(09)70047-4
18. Harandi A, Zaidi AS, Stocker AM, Laber DA (2009) Clinical efficacy and toxicity of anti-EGFR therapy in common cancers. J Oncol 2009:567486
19. Cronin CG, O'Connor M, Lohan DG, et al. (2009) Imaging of the gastrointestinal complications of systemic chemotherapy. Clin Radiol 64(7):724-733
20. Toghill PJ, Burke JD (1970) Death from paralytic ileus following vincristine therapy. Postgrad Med J 46(535):330-331
21. Hashimoto S, Saitoh H, Wada K, et al. (1995) Pneumatosis cystoides intestinalis after chemotherapy for hematological malignancies: report of 4 cases. Intern Med 34(3):212-215
22. St Peter SD, Abbas MA, Kelly KA (2003) The spectrum of pneumatosis intestinalis. Arch Surg 138(1):68-75 (Pubitemid 36055653)
23. Shanbhogue AK, Virmani V, Vikram R, et al. (2011) Spectrum of medication-induced complications in the abdomen: role of cross-sectional imaging. AJR Am J Roentgenol 197(2):W286-W294. doi: 10.2214/ajr.10.5415
24. Gorschluter M, Mey U, Strehl J, et al. (2005) Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 75(1):1-13. doi: 10.1111/j.1600-0609.2005.00442.x (Pubitemid 40873955)
25. Wade DS, Nava HR, Douglass HO Jr (1992) Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 69(1):17-23
26. Frick MP, Maile CW, Crass JR, Goldberg ME, Delaney JP (1984) Computed tomography of neutropenic colitis. AJR Am J Roentgenol 143(4):763-765 (Pubitemid 14044652)
27. Kirkpatrick ID, Greenberg HM (2003) Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 226(3):668-674 (Pubitemid 36259140)
28. Thoeni RF, Cello JP (2006) CT imaging of colitis. Radiology 240(3):623-638. doi: 10.1148/radiol.2403050818 (Pubitemid 44267317)
29. Ibrahim NK, Sahin AA, Dubrow RA, et al. (2000) Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet 355(9200):281-283. doi: 10.1016/s0140-6736(99)06195-4 (Pubitemid 30068521)
30. Kreis W, Petrylak D, Savarese D, Budman D (2000) Colitis and docetaxel-based chemotherapy. Lancet 355(9221):2164. doi: 10.1016/s0140-6736(05) 72789-6 (Pubitemid 30364674)
31. Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17(1):109-113 (Pubitemid 23197574)
32. Macari M, Balthazar EJ, Megibow AJ (1999) The accordion sign at CT: a nonspecific finding in patients with colonic edema. Radiology 211(3):743-746 (Pubitemid 29249474)
33. Hapani S, Chu D, Wu S (2009) Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 10(6):559-568
34. Bonifazi M, Rossi M, Moja L, et al. (2012) Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety. Oncologist 17(1):117-124. doi: 10.1634/theoncologist.2011-0184
35. Han ES, Monk BJ (2007) What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer? Gynecol Oncol 105(1):3-6. doi: 10.1016/j.ygyno.2007.01.038 (Pubitemid 46441477)
36. Garant A, Des Groseilliers S, Martin L, Ferland E, Vuong T (2011) Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer. Clin Oncol 23(7):497-498. doi: 10.1016/j.clon.2011.03.009
37. Rose PG, Piver MS (1995) Intestinal perforation secondary to paclitaxel. Gynecol Oncol 57(2):270-272. doi: 10.1006/gyno.1995.1140
38. Liaw CC, Huang JS, Wang HM, Wang CH (1993) Spontaneous gastroduodenal perforation in patients with cancer receiving chemotherapy and steroids. Report of four cases combining 5-fluorouracil infusion and cisplatin with antiemetics dexamethasone. Cancer 72(4):1382-1385
39. Schwartzentruber D, Lotze MT, Rosenberg SA (1988) Colonic perforation. An unusual complication of therapy with high-dose interleukin-2. Cancer 62(11):2350-2353
40. Hecker A, Hecker B, Bassaly B, et al. (2010) Dramatic regression and bleeding of a duodenal GIST during preoperative imatinib therapy: case report and review. World J Surg Oncol 8:47. doi: 10.1186/1477-7819-8-47
41. Hong X, Choi H, Loyer EM, et al. (2006) Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics 26(2):481-495 (Pubitemid 43515319)
42. Talamonti MS, Dawes LG, Joehl RJ, Nahrwold DL (1990) Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg 125(8):972-976 ((discussion 976-977))
43. Meyers PA, Potter VP, Wollner N, Exelby P (1985) Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma. Cancer 56(2):259-261 (Pubitemid 15031643)
44. Coia LR, Myerson RJ, Tepper JE (1995) Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 31(5):1213-1236
45. Henriksson R, Bergstrom P, Franzen L, Lewin F, Wagenius G (1999) Aspects on reducing gastrointestinal adverse effects associated with radiotherapy. Acta Oncol 38(2):159-164 (Pubitemid 29179769)
46. Wobbes T, Verschueren RC, Lubbers EJ, Jansen W, Paping RH (1984) Surgical aspects of radiation enteritis of the small bowel. Dis Colon Rectum 27(2):89-92 (Pubitemid 14176302)
47. Perrakis N, Athanassiou E, Vamvakopoulou D, et al. (2011) Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery. World J Gastroenterol 17(35):4013-4016. doi: 10.3748/wjg.v17.i35.4013
48. Horton KM, Corl FM, Fishman EK (1999) CT of nonneoplastic diseases of the small bowel: spectrum of disease. J Comput Assist Tomogr 23(3):417-428 (Pubitemid 29235156)
49. Hauer-Jensen M (1990) Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review. Acta Oncol 29(4):401-415 (Pubitemid 20262584)
50. Capps GW, Fulcher AS, Szucs RA, Turner MA (1997) Imaging features of radiation-induced changes in the abdomen. Radiographics 17(6):1455-1473 (Pubitemid 127466067)
51. Sugimura K, Carrington BM, Quivey JM, Hricak H (1990) Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 175(3):805-813 (Pubitemid 20191950)
52. Donner CS (1998) Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 16(4):253-261 (Pubitemid 128531139)
53. Khan AZ, Morris-Stiff G, Makuuchi M (2009) Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 16(2):137-144. doi: 10.1007/s00534-008-0016-z
54. Chun YS, Laurent A, Maru D, Vauthey JN (2009) Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 10(3):278-286. doi: 10.1016/s1470-2045(09)70064-6
55. McCullough AJ (2006) Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 40(Suppl 1):S17-S29. doi: 10.1097/01.mcg.0000168645.86658.22 (Pubitemid 44309539)
56. Belghiti J, Hiramatsu K, Benoist S, et al. (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38-46 (Pubitemid 30439557)
57. Gomez D, Malik HZ, Bonney GK, et al. (2007) Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 94(11):1395-1402. doi: 10.1002/bjs.5820 (Pubitemid 350144389)
58. Kooby DA, Fong Y, Suriawinata A, et al. (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7(8):1034-1044 (Pubitemid 37524071)
59. Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK (2006) Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 12(40):6556-6558 (Pubitemid 44742595)
60. Vauthey JN, Pawlik TM, Ribero D, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24(13):2065-2072. doi: 10.1200/jco.2005.05.3074 (Pubitemid 46622116)
61. Zorzi D, Laurent A, Pawlik TM, et al. (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94(3):274-286. doi: 10.1002/bjs.5719 (Pubitemid 46423843)
62. Hamer OW, Aguirre DA, Casola G, et al. (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26(6):1637-1653. doi: 10.1148/rg.266065004
63. Joy D, Thava VR, Scott BB (2003) Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15(5):539-543. doi: 10.1097/01.meg.0000059112.41030.2e (Pubitemid 36571048)
64. Blachar A, Federle MP, Sosna J (2009) Liver lesions with hepatic capsular retraction. Semin Ultrasound CT MR 30(5):426-435
65. Fennessy FM, Mortele KJ, Kluckert T, et al. (2004) Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. AJR Am J Roentgenol 182(3):651-655 (Pubitemid 38269525)
66. Young ST, Paulson EK, Washington K, et al. (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 163(6):1385-1388
67. Qayyum A, Lee GK, Yeh BM, et al. (2007) Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging 31(1):6-10. doi: 10.1016/j.clinimag.2006.09.028 (Pubitemid 44960640)
68. Shirkhoda A, Baird S (1994) Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging 19(1):39-42 (Pubitemid 24007605)
69. Cefalo MG, Maurizi P, Arlotta A, et al. (2010) Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies. Paediatr Drugs 12(5):277-284. doi: 10.2165/11531840-000000000-00000
70. Lassau N, Leclere J, Auperin A, et al. (1997) Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. Radiology 204(2):545-552 (Pubitemid 27337510)
71. Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB (1994) Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 19(5):1171-1181
72. Robinson S, Manas DM, Pedley I, Mann D, White SA (2011) Systemic chemotherapy and its implications for resection of colorectal liver metastasis. Surg Oncol 20(2):57-72. doi: 10.1016/j.suronc.2009.10.002
73. Richardson P, Guinan E (1999) The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches. Br J Haematol 107(3):485-493
74. Erturk SM, Mortele KJ, Binkert CA, et al. (2006) CT features of hepatic venoocclusive disease and hepatic graft-versus-host disease in patients after hematopoietic stem cell transplantation. AJR Am J Roentgenol 186(6):1497-1501 (Pubitemid 46112510)
75. Mahgerefteh SY, Sosna J, Bogot N, et al. (2011) Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology 258(3):660-671. doi: 10.1148/radiol. 10100025
76. Nakano H, Oussoultzoglou E, Rosso E, et al. (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247(1):118-124. doi: 10.1097/SLA.0b013e31815774de
77. Slade JH, Alattar ML, Fogelman DR, et al. (2009) Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8(4):225-230. doi: 10.3816/CCC.2009.n.038
78. Tisman G, MacDonald D, Shindell N, et al. (2004) Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 22(15):3202-3204. doi: 10.1200/jco.2004.99.106
79. Khozouz RF, Huq SZ, Perry MC (2008) Radiation-induced liver disease. J Clin Oncol 26(29):4844-4845
80. Iyer RB, Balachandran A, Bruzzi JF, et al. (2007) PET/CT and hepatic radiation injury in esophageal cancer patients. Cancer Imaging 7:189-194. doi: 10.1102/1470-7330.2007.0027
81. DeLappe EM, Truong MT, Bruzzi JF, Swisher SG, Rohren EM (2009) Hepatic radiation injury mimicking a metastasis on positron-emission tomography/computed tomography in a patient with esophageal carcinoma. J Thorac Oncol 4(11):1442-1444
82. Mahmoud H, Schell M, Pui CH (1991) Cholelithiasis after treatment for childhood cancer. Cancer 67(5):1439-1442
83. Buyukasik Y, Kosar A, Demiroglu H, et al. (1998) Acalculous acute cholecystitis in leukemia. J Clin Gastroenterol 27(2):146-148 (Pubitemid 28432266)
84. Kobbe G, Heyll A, Zodler T, et al. (1997) Acute acalculous cholecystitis complicating oral recontamination after allogeneic bone marrow transplantation. Oncol Rep 4(4):823-824 (Pubitemid 27286999)
85. Barnett KT, Malafa MP (2001) Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer 30(3):147-160. doi: 10.1385/ijgc:30:3:147 (Pubitemid 36306730)
86. Sandrasegaran K, Alazmi WM, Tann M, et al. (2006) Chemotherapy-induced sclerosing cholangitis. Clin Radiol 61(8):670-678. doi: 10.1016/j.crad.2006.02. 013 (Pubitemid 44028493)
87. Botet JF, Watson RC, Kemeny N, Daly JM, Yeh S (1985) Cholangitis complicating intraarterial chemotherapy in liver metastasis. Radiology 156(2):335-337 (Pubitemid 15029759)
88. Phongkitkarun S, Kobayashi S, Varavithya V, et al. (2005) Bile duct complications of hepatic arterial infusion chemotherapy evaluated by helical CT. Clin Radiol 60(6):700-709. doi: 10.1016/j.crad.2005.01.006 (Pubitemid 40984066)
89. Morgan C, Tillett T, Braybrooke J, Ajithkumar T (2011) Management of uncommon chemotherapy-induced emergencies. Lancet Oncol 12(8):806-814. doi: 10.1016/s1470-2045(10)70208-4
90. Sugarbaker PH, Alderman R, Edwards G, et al. (2006) Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13(5):635-644
91. Ruinemans GM, Balemans C, Mattijssen V, Wiersma-van Tilburg AJ, Smit HJ (2010) Fatal necrotizing pancreatitis during combined treatment with erlotinib and sunitinib. Lung Cancer 70(3):364-365. doi: 10.1016/j.lungcan.2010.08.004
92. Motzer RJ, Rini BI, Bukowski RM, et al. (2006) Sunitinib in patients with metastatic renal cell carcinoma. JAMA 295(21):2516-2524. doi: 10.1001/jama.295.21.2516 (Pubitemid 43854967)
93. Li M, Srinivas S (2007) Acute pancreatitis associated with sorafenib. South Med J 100(9):909-911 (Pubitemid 47367933)
94. Levy P, Menzelxhiu A, Paillot B, et al. (1993) Abdominal radiotherapy is a cause for chronic pancreatitis. Gastroenterology 105(3):905-909 (Pubitemid 23249503)
95. Elliott MA, Mesa RA, Tefferi A (2002) Adverse events after imatinib mesylate therapy. N Engl J Med 346(9):712-713. doi: 10.1056/NEJM200202283460919 (Pubitemid 34815885)
96. Masood N, Shaikh AJ, Memon WA, Idress R (2008) Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature. Cases J 1(1):418
97. Aapro MS, Cameron DA, Pettengell R, et al. (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42(15):2433-2453. doi: 10.1016/j.ejca.2006.05.002 (Pubitemid 44442936)
98. Lionne-Huyghe P, Kuhnowski F, Coiteux V, Bauters F, Morschhauser F (2006) Indications of G-CSF administration in hematologic disorders. Bull Cancer 93(5):453-462 (Pubitemid 43965766)
99. Tigue CC, McKoy JM, Evens AM, et al. (2007) Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transpl 40(3):185-192. doi: 10.1038/sj.bmt.1705722 (Pubitemid 47108460)
100. Nuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A (2006) Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (G-CSF). A case report and review of the literature. Haematologica 91(Suppl 5):ECR08
101. Hernandez R, del Canizo MC, Lopez C, et al. (2000) Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia. Med Oncol 17(4):337-339
102. Lubner M, Menias C, Rucker C, et al. (2007) Blood in the belly: CT findings of hemoperitoneum. Radiographics 27(1):109-125
103. Miura K, Nakano H, Sakurai J, et al. (2011) Splenomegaly in FOLFOX-naive stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy. Int J Clin Oncol 16(3):257-263. doi: 10.1007/s10147-010-0176-0
104. Overman MJ, Maru DM, Charnsangavej C, et al. (2010) Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28(15):2549-2555. doi: 10.1200/jco.2009.27.5701
105. Ezra N, Goltche NB, Hakimian S, Afari A (2010) CTLA4-induced splenomegaly and a review of the literature pertaining to autoimmune complications of therapy. J Drugs Dermatol 9(11):1432-1436
106. Iyer R, Jhingran A (2006) Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging 6:S131-S139. doi: 10.1102/1470-7330.2006.9095
107. de Jonge MJ, Verweij J (2006) Renal toxicities of chemotherapy. Semin Oncol 33(1):68-73. doi: 10.1053/j.seminoncol.2005.11.011 (Pubitemid 43214487)
108. Kelly RJ, Billemont B, Rixe O (2009) Renal toxicity of targeted therapies. Target Oncol 4(2):121-133. doi: 10.1007/s11523-009-0109-x
109. Del Toro G, Morris E, Cairo MS (2005) Tumor lysis syndrome: pathophysiology, definition, and alternative treatment approaches. Clin Adv Hematol Oncol 3(1):54-61 (Pubitemid 40277560)
110. Davidson MB, Thakkar S, Hix JK, et al. (2004) Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med 116(8):546-554. doi: 10.1016/j.amjmed.2003.09.045 (Pubitemid 38452647)
111. Jones DP, Mahmoud H, Chesney RW (1995) Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 9(2):206-212
112. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16):2767-2778. doi: 10.1200/jco.2007.15.0177
113. Stillwell TJ, Benson RC Jr (1988) Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 61(3):451-457 (Pubitemid 18039357)
114. Talar-Williams C, Hijazi YM, Walther MM, et al. (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124(5):477-484 (Pubitemid 26070112)
115. Benya EC, Sivit CJ, Quinones RR (1993) Abdominal complications after bone marrow transplantation in children: sonographic and CT findings. AJR Am J Roentgenol 161(5):1023-1027 (Pubitemid 23333165)
116. Coy DL, Ormazabal A, Godwin JD, Lalani T (2005) Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation. Radiographics 25(2):305-317 ((discussion 318)). doi: 10.1148/rg.252045037 (Pubitemid 40547046)
117. McCarville MB, Hoffer FA, Gingrich JR, Jenkins JJ III (2000) Imaging findings of hemorrhagic cystitis in pediatric oncology patients. Pediatr Radiol 30(3):131-138 (Pubitemid 30156473)
118. Lawson M, Vasilaras A, De Vries A, Mactaggart P, Nicol D (2008) Urological implications of cyclophosphamide and ifosfamide. Scand J Urol Nephrol 42(4):309-317. doi: 10.1080/00365590701570953
119. Wheeler JS Jr, Siroky MB, Bell R, Babayan RK (1983) Vincristine-induced bladder neuropathy. J Urol 130(2):342-343 (Pubitemid 13037619)
120. Shimura K, Shimazaki C, Taniguchi K, et al. (2009) Bortezomib-induced neurogenic bladder in patients with multiple myeloma. Ann Hematol 88(4):383-384. doi: 10.1007/s00277-008-0614-5
121. Citak EC, Oguz A, Karadeniz C, et al. (2008) Vincristine-induced peripheral neuropathy and urinary bladder paralysis in a child with rhabdomyosarcoma. J Pediatr Hematol Oncol 30(1):61-62. doi: 10.1097/MPH. 0b013e318158343b
122. Charnsangavej C, Cinqualbre A, Wallace S (1994) Radiation changes in the liver, spleen, and pancreas: imaging findings. Semin Roentgenol 29(1):53-63 (Pubitemid 24036615)
123. Marks LB, Carroll PR, Dugan TC, Anscher MS (1995) The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31(5):1257-1280
124. Addar MH, Stuart GC, Nation JG, Shumsky AG (1996) Spontaneous rupture of the urinary bladder: a late complication of radiotherapy - case report and review of the literature. Gynecol Oncol 62(2):314-316. doi: 10.1006/gyno.1996. 0234 (Pubitemid 26274818)
125. Parliament M, Genest P, Girard A, Gerig L, Prefontaine M (1989) Obstructive ureteropathy following radiation therapy for carcinoma of the cervix. Gynecol Oncol 33(2):237-240 (Pubitemid 19112921)
126. Ascher SM, Imaoka I, Lage JM (2000) Tamoxifen-induced uterine abnormalities: the role of imaging. Radiology 214(1):29-38 (Pubitemid 30019866)
127. Fong K, Causer P, Atri M, Lytwyn A, Kung R (2003) Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study. Radiographics 23(1):137-150 ((discussion 151-135)) (Pubitemid 37421443)
128. Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94(2):256-266. doi: 10.1016/j.ygyno.2004.03. 048 (Pubitemid 39024525)
129. Kazerooni T, Ghaffarpasand F, Mosalaei A, Kazerooni Y (2010) The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen. Med Princ Pract 19(3):222-227. doi: 10.1159/000285296
130. Manfredi R, Gui B, Maresca G, Fanfani F, Bonomo L (2005) Endometrial cancer: magnetic resonance imaging. Abdom Imaging 30(5):626-636. doi: 10.1007/s00261-004-0298-9 (Pubitemid 41446684)
131. Weaver J, McHugo JM, Clark TJ (2005) Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen. Br J Radiol 78(929):394-397. doi: 10.1259/bjr/60976544 (Pubitemid 40691740)
132. Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E (2010) Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies. Radiographics 30(7):1843-1856. doi: 10.1148/rg.307105063
133. Elice F, Rodeghiero F, Falanga A, Rickles FR (2009) Thrombosis associated with angiogenesis inhibitors. Best Pract Res Clin Haematol 22(1):115-128. doi: 10.1016/j.beha.2009.01.001
134. Harding GE, Lawlor DK (2007) Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guerin. J Vasc Surg 46(1):131-134. doi: 10.1016/j.jvs.2007.01.054 (Pubitemid 46990735)
135. Fajardo LF (1999) Is the pathology of radiation injury different in small vs. large blood vessels? Cardiovasc Radiat Med 1(1):108-110
136. Libshitz HI (1994) Radiation changes in bone. Semin Roentgenol 29(1):15-37 (Pubitemid 24036613)
137. Hall EJ, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56(1):83-88 (Pubitemid 36403679)
138. Sheppard DG, Libshitz HI (2001) Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin Radiol 56(1):22-29. doi: 10.1053/crad.2000.0599 (Pubitemid 32685180)
139. Schmit M, Bethge W, Beck R, et al. (2008) CT of gastrointestinal complications associated with hematopoietic stem cell transplantation. AJR Am J Roentgenol 190(3):712-719 (Pubitemid 351304516)
140. Thomas ED (1999) Bone marrow transplantation: a review. Semin Hematol 36(4 Suppl 7):95-103
141. Levine DS, Navarro OM, Chaudry G, Doyle JJ, Blaser SI (2007) Imaging the complications of bone marrow transplantation in children. Radiographics 27(2):307-324
142. Jones B, Fishman EK, Kramer SS, et al. (1986) Computed tomography of gastrointestinal inflammation after bone marrow transplantation. AJR Am J Roentgenol 146(4):691-695 (Pubitemid 16117257)
143. Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z (2005) Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol 60(1):47-55. doi: 10.1016/j.crad.2004.08.016 (Pubitemid 40103899)
144. Jacobsohn DA, Vogelsang GB (2007) Acute graft versus host disease. Orphanet J Rare Dis 2:35. doi: 10.1186/1750-1172-2-35